Similar Papers

Paper Title
Journal
Date
Author
Use of ECMO in Patients With Coronavirus Disease 2019: Does the Evidence Suffice?
Samiha Alom ... Amer Harky
Journal of Cardiothoracic and Vascular Anesthesia | VOL. 35
Samiha Alom, et. al.Samiha Alom ... Amer Harky
30 Jul 2020
Increased Intracranial Hemorrhage Amid Elevated Inflammatory Markers in Those With COVID-19 Supported With Extracorporeal Membrane Oxygenation.
Rene S Bermea ... Jerome Crowley
Shock (Augusta, Ga.) | VOL. 56
Rene S Bermea, et. al.Rene S Bermea ... Jerome Crowley
20 Jan 2021
Acute Respiratory Distress Syndrome Treated With Awake Extracorporeal Membrane Oxygenation in a Patient With COVID-19 Pneumonia
Tong Li ... Yong-Xing Yao
Journal of Cardiothoracic and Vascular Anesthesia | VOL. 35
Tong Li, et. al.Tong Li ... Yong-Xing Yao
10 Nov 2020
Peripartum use of Extracorporeal Membrane Oxygenation (ECMO) in a Patient Suffering from COVID-19 Severe Acute Respiratory Distress Syndrome (ARDS): A Case Report
Jay Conhaim ... Braxton Forde
-
Jay Conhaim, et. al.Jay Conhaim ... Braxton Forde
27 Apr 2020
View more papers

More From: Rheumatology Advances in Practice

Paper Title
Journal
Date
Author
Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of ustekinumab in patients with Takayasu arteritis
Hajime Yoshifuji ... Yoshikazu Nakaoka
Rheumatology Advances in Practice | VOL. -
Hajime Yoshifuji, et. al.Hajime Yoshifuji ... Yoshikazu Nakaoka
03 Feb 2025
BASDAI and ASDAS disease states in relationship to ASAS40 response: post-hoc analysis of ixekizumab in radiographic axial spondyloarthritis
Martin Rudwaleit ... Jean Dudler
Rheumatology Advances in Practice | VOL. -
Martin Rudwaleit, et. al.Martin Rudwaleit ... Jean Dudler
29 Jan 2025
Long-term tofacitinib efficacy and safety in psoriatic arthritis with or without prior biologic DMARD exposure: a post hoc analysis
Dafna D Gladman ... Peter Nash
Rheumatology Advances in Practice | VOL. -
Dafna D Gladman, et. al.Dafna D Gladman ... Peter Nash
21 Jan 2025
Long-term tofacitinib efficacy and safety in psoriatic arthritis with or without prior biologic DMARD exposure: a post hoc analysis
Dafna D Gladman ... Peter Nash
Rheumatology Advances in Practice | VOL. -
Dafna D Gladman, et. al.Dafna D Gladman ... Peter Nash
21 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.